The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis.
Saved in:
| Title: | The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis. |
|---|---|
| Authors: | Bingaman MG; InNexus Biotechnology Inc, Scottsdale, Arizona, USA., Basu GD, Golding TC, Chong SK, Lassen AJ, Kindt TJ, Lipinski CA |
| Source: | Anti-cancer drugs [Anticancer Drugs] 2010 Jun; Vol. 21 (5), pp. 532-42. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20216307 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bingaman+MG%22">Bingaman MG</searchLink>; InNexus Biotechnology Inc, Scottsdale, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Basu+GD%22">Basu GD</searchLink><br /><searchLink fieldCode="AU" term="%22Golding+TC%22">Golding TC</searchLink><br /><searchLink fieldCode="AU" term="%22Chong+SK%22">Chong SK</searchLink><br /><searchLink fieldCode="AU" term="%22Lassen+AJ%22">Lassen AJ</searchLink><br /><searchLink fieldCode="AU" term="%22Kindt+TJ%22">Kindt TJ</searchLink><br /><searchLink fieldCode="AU" term="%22Lipinski+CA%22">Lipinski CA</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229100823%22">Anti-cancer drugs</searchLink> [Anticancer Drugs] 2010 Jun; Vol. 21 (5), pp. 532-42. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9100823 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-5741 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209594973%22">09594973 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20216307 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/CAD.0b013e328337d485 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 532 Titles: – TitleFull: The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bingaman MG – PersonEntity: Name: NameFull: Basu GD – PersonEntity: Name: NameFull: Golding TC – PersonEntity: Name: NameFull: Chong SK – PersonEntity: Name: NameFull: Lassen AJ – PersonEntity: Name: NameFull: Kindt TJ – PersonEntity: Name: NameFull: Lipinski CA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2010 Jun Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1473-5741 Numbering: – Type: volume Value: 21 – Type: issue Value: 5 Titles: – TitleFull: Anti-cancer drugs Type: main |
| ResultId | 1 |